Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience

Oren Pasvolsky, Denái R. Milton, Adeel Masood, Sophiya S. Sami, Mark R. Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Arsalan Saeed, Hans C. Lee, Krina K. Patel, Partow Kebriaei, Sheeba K. Thomas, Donna M. Weber, Robert Z. Orlowski, Elizabeth J. Shpall, Richard E. ChamplinMuzaffar H. Qazilbash^*

^*Corresponding author for this work

Hematology

University of Texas MD Anderson Cancer Center
Rabin Medical Center Israel

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Sort by
Weight
Alphabetically

Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience

Fingerprint

Keyphrases

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry

Immunology and Microbiology

Neuroscience